Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31926818)

  • 1. Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England.
    Boyle JM; Kuryba A; Cowling TE; Aggarwal A; Hill J; van der Meulen J; Walker K; Braun MS
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):e135-e144. PubMed ID: 31926818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands.
    van Steenbergen LN; Rutten HJT; Creemers GJ; Pruijt JFM; Coebergh JWW; Lemmens VEPP
    Ann Oncol; 2010 Jun; 21(6):1273-1278. PubMed ID: 19880434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
    Schrag D; Cramer LD; Bach PB; Begg CB
    J Natl Cancer Inst; 2001 Jun; 93(11):850-7. PubMed ID: 11390534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer.
    Karim S; Booth CM; Brennan K; Peng Y; Siemens DR; Krzyzanowska MK; Mackillop WJ
    Cancer Med; 2019 Sep; 8(12):5590-5599. PubMed ID: 31407518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
    Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
    Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.
    Babaei M; Balavarca Y; Jansen L; Lemmens V; van Erning FN; van Eycken L; Vaes E; Sjövall A; Glimelius B; Ulrich CM; Schrotz-King P; Brenner H
    Int J Cancer; 2018 Apr; 142(7):1480-1489. PubMed ID: 29159866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general population.
    Merchant SJ; Nanji S; Brennan K; Karim S; Patel SV; Biagi JJ; Booth CM
    Cancer; 2017 Aug; 123(15):2840-2849. PubMed ID: 28346663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
    Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
    J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
    [No Abstract]   [Full Text] [Related]  

  • 11. Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer.
    Daly MC; Hanseman DJ; Abbott DE; Shah SA; Paquette IM
    Dis Colon Rectum; 2016 Dec; 59(12):1134-1141. PubMed ID: 27824698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
    Jessup JM; Stewart A; Greene FL; Minsky BD
    JAMA; 2005 Dec; 294(21):2703-11. PubMed ID: 16333005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing Use of Chemotherapy in Older Patients With Stage III Colon Cancer Irrespective of Comorbidities.
    Walter V; Boakye D; Weberpals J; Jansen L; Haefeli WE; Martens UM; Knebel P; Chang-Claude J; Hoffmeister M; Brenner H
    J Natl Compr Canc Netw; 2019 Sep; 17(9):1089-1099. PubMed ID: 31487678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
    Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
    Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
    van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
    Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):e29-e38. PubMed ID: 27663601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
    Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
    J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.